148 related articles for article (PubMed ID: 9412663)
1. Breast cancer: cell and gene therapy.
Lebkowski JS; Philip R; Okarma TB
Cancer Invest; 1997; 15(6):568-76. PubMed ID: 9412663
[No Abstract] [Full Text] [Related]
2. Processing of hematopoietic stem cells: purging or selection?
Slaper-Cortenbach IC
Vox Sang; 1994; 67 Suppl 3():185-6. PubMed ID: 7526552
[No Abstract] [Full Text] [Related]
3. High-dose chemotherapy and autologous stem cell transplantation for breast cancer.
Weaver CH; Birch R; Schwartzberg LS; West WH
Cancer Treat Res; 1995; 76():59-85. PubMed ID: 7577345
[No Abstract] [Full Text] [Related]
4. Autologous bone marrow support and bone disease in metastatic breast cancer.
Nabholtz JM; al-Tweigeri T; Jacquelin N; Venner PM
Can J Oncol; 1995 Jul; 5(2):369-75. PubMed ID: 8853509
[TBL] [Abstract][Full Text] [Related]
5. Purging of autologous bone marrow for transplantation: the protection and selection of the hematopoietic progenitor cell.
Shpall EJ; Stemmer SM; Johnston CF; Hami L; Bearman SI; Berenson R; Jones RB
J Hematother; 1992; 1(1):45-54. PubMed ID: 1365017
[TBL] [Abstract][Full Text] [Related]
6. New developments in stem cell detection and stem cell selection in the context of autologous transplantations.
Douay L; Lopez M; Giarratana MC; Bony V; Bouchet S; Gorin NC
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):87-9. PubMed ID: 8099734
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow metastases.
Shpall EJ; Gee AP; Hogan C; Cagnoni P; Gehling U; Hami L; Franklin W; Bearman SI; Ross M; Jones RB
Hematol Oncol Clin North Am; 1996 Apr; 10(2):321-43. PubMed ID: 8707758
[TBL] [Abstract][Full Text] [Related]
8. Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients.
Schulze R; Schulze M; Wischnik A; Ehnle S; Doukas K; Behr W; Ehret W; Schlimok G
Bone Marrow Transplant; 1997 Jun; 19(12):1223-8. PubMed ID: 9208116
[TBL] [Abstract][Full Text] [Related]
9. Mononuclear and CD34+ stem cell recovery after automated Ficoll processing of marrow or peripheral blood stem cells for transplantation.
Cottler-Fox M; Read EJ; Yu M; Carter C; Klein HG
Prog Clin Biol Res; 1992; 377():569-73. PubMed ID: 1279726
[No Abstract] [Full Text] [Related]
10. Should soybean agglutinin purging be performed in breast cancer patients undergoing autologous stem cell transplantation? A retrospective analysis of 48 patients.
Ben-Yosef R; Or R; Naparstek E; Kapelushnik J; Samuels S; Slavin S; Nagler A
Am J Clin Oncol; 1997 Aug; 20(4):419-23. PubMed ID: 9256903
[TBL] [Abstract][Full Text] [Related]
11. Biological purging of breast cancer cells using an attenuated replication-competent herpes simplex virus in human hematopoietic stem cell transplantation.
Wu A; Mazumder A; Martuza RL; Liu X; Thein M; Meehan KR; Rabkin SD
Cancer Res; 2001 Apr; 61(7):3009-15. PubMed ID: 11306480
[TBL] [Abstract][Full Text] [Related]
12. Autologous bone marrow support and bone disease in metastatic breast cancer.
Nabholtz JM; al-Tweigeri T; Jacquelin N; Venner PM
Can J Oncol; 1995 Dec; 5 Suppl 1():33-9. PubMed ID: 8853522
[TBL] [Abstract][Full Text] [Related]
13. High-dose chemotherapy with autologous bone marrow transplantation for the treatment of breast cancer: yes.
Peters WP
Important Adv Oncol; 1995; ():215-30. PubMed ID: 7672808
[No Abstract] [Full Text] [Related]
14. Gene marking after bone marrow transplantation.
Brenner MK; Rill DR; Heslop HE; Rooney CM; Roberts WM; Li C; Nilson T; Krance RA
Eur J Cancer; 1994; 30A(8):1171-6. PubMed ID: 7654451
[No Abstract] [Full Text] [Related]
15. Stem cell manipulation: why and how performing peripheral blood progenitor cell purging.
Rizzoli V; Carlo-Stella C
Crit Rev Oncol Hematol; 1997 Jul; 26(2):101-15. PubMed ID: 9298327
[No Abstract] [Full Text] [Related]
16. Ex vivo expansion of bone marrow from breast cancer patients: reduction in tumor cell content through passive purging.
Lundell BI; Vredenburgh JJ; Tyer C; DeSombre K; Smith AK
Bone Marrow Transplant; 1998 Jul; 22(2):153-9. PubMed ID: 9707023
[TBL] [Abstract][Full Text] [Related]
17. Efficient and nontoxic adenoviral purging method for autologous transplantation in breast cancer patients.
Lillo R; Ramírez M; Alvarez A; Santos S; García-Castro J; Fernández de Velasco J; Avilés MJ; Gómez-Pineda A; Díez JL; Balas A; Vicario JL; Bueren JA; García-Sánchez F
Cancer Res; 2002 Sep; 62(17):5013-8. PubMed ID: 12208755
[TBL] [Abstract][Full Text] [Related]
18. The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation.
Peters WP; Kurtzberg J; Atwater S; Borowitz M; Rao M; Currie M; Gilbert C; Shpall EJ; Jones RB; Ross M
Prog Clin Biol Res; 1990; 338():121-8. PubMed ID: 2189135
[No Abstract] [Full Text] [Related]
19. New strategies in marrow purging for breast cancer patients receiving high-dose chemotherapy with autologous bone marrow transplantation.
Shpall EJ; Stemmer SM; Bearman SI; Myers S; Purdy M; Jones RB
Breast Cancer Res Treat; 1993; 26 Suppl():S19-23. PubMed ID: 7691269
[TBL] [Abstract][Full Text] [Related]
20. High-dose chemotherapy and autologous bone marrow plus peripheral blood stem cell transplantation for patients with lymphoma or metastatic breast cancer: use of marker genes to investigate hematopoietic reconstitution in adults.
Douer D; Levine A; Anderson WF; Gordon M; Groshen S; Khan A; Mohrbacher A; Muggia F; Shibata D
Hum Gene Ther; 1996 Mar; 7(5):669-84. PubMed ID: 8845392
[No Abstract] [Full Text] [Related]
[Next] [New Search]
